{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-041802","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2024-10-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.387290+00:00","generated_at":"2026-05-30T12:32:31.390439+00:00","sec_items":["7.01","9.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"MangoRx faces Eli Lilly lawsuit over alleged copying of weight-loss drugs Zepbound/Mounjaro","bullets":["Eli Lilly filed a lawsuit claiming MangoRx improperly copied its weight-loss medicines Zepbound and Mounjaro.","MangoRx strongly refutes all claims regarding the sale of compounded tirzepatide and will vigorously defend.","MangoRx provides access to compounded tirzepatide via its telemedicine platform for men's health and wellness.","No financial details or specific damages claimed are disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-041802","json":"https://secwatch.observer/filing/0001493152-24-041802.json","markdown":"https://secwatch.observer/filing/0001493152-24-041802.md","text":"https://secwatch.observer/filing/0001493152-24-041802.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000149315224041802/0001493152-24-041802-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000149315224041802/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T12:32:31.390439+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}